Gefitinib Accord

Gefitinib Accord is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Accord Healthcare B.V. and is designed for targeted therapy.

Gefitinib Accord is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic features. It works by targeting and inhibiting the growth of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its role as a targeted therapy for cancer treatment.

Common effects of Gefitinib Accord may include skin rash, diarrhea, and nausea. Some users might experience fatigue or loss of appetite. It's important to monitor these effects and consult a healthcare provider if they become severe.

Gefitinib Accord should be handled with care, especially by those with pre-existing medical conditions. It is crucial to follow the prescribed guidelines and avoid self-medication. Always store the medication in a safe place, away from children and pets.

Gefitinib Accord may interact with certain medications, including those that are metabolized by the liver. It's advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.